Health Condition 1: null- Metabolic syndrome
Conditions
Interventions
Intervention1: The dried rhizome of Dioscorea bulbifera, Fruits of Hippophae rhamnoides, Fruits & Seeds of Terminalia chebula, Bark of Terminalia arjuna and Rhizome of Nardostachys jatamansi were util
Terminalia arjuna 75mg
Terminalia chebbula 100 mg
Hippophae rhamnoides 112.5 mg
Nardostachys jatamansi 62.5mg and additives: 25 mg (CaCO3)) was prepared. The drug was administered 1 capsule twice in day i.e. 1 capsule morning after breakfast (8 am) and 1 capsule evening after me
Sponsors
Dr Jeevan Sharma MD Ay
Dr Aruna Agrawal PhD
Dr Jeevan Sharma
Dr K Srinath MD
Dr Satish Kumar Balian Md Ay
Dr Vijay Chaudhary
Prof BN Upadhyay MD Ay PhD
Prof KS Laxmi
Prof RG Singh MD DM Nephrology
Eligibility
Inclusion criteria
Inclusion criteria: 1.Triglycerides >150 mg% 2.Abdominal girth Male > 102 cm and Female > 85 cm 3.BP systolic > 130 mm Hg and Diastolic > 85 mm Hg 4.HDL 5.Fasting Blood Sugar > 100 mg%
Exclusion criteria
Exclusion criteria: 1. FBS 2. TG 3. BP Systolic
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevention and management of metabolic syndrome by a novel Ayurvedic formulation was carried out and the therapeutic potential of test drug was established. Further the future occurrence of adverse cardiac event was assessed among selected cases.Timepoint: 5 Years | — |
Secondary
| Measure | Time frame |
|---|---|
| The Metabolic syndrome cases with insulin resistance were prevented from fulflaged manifestation of diabetes, prevented from Renal and cardiac invovlement. Reduction in obesity and hypertension following test formulation treatment in Metabolic syndrome patients prevented them from development of coronary heart disease and premature death as well.Timepoint: From baseline to 10 years | — |
Countries
India
Contacts
Public ContactDr R G Singh
Institute of Medical Sceicnes
Outcome results
None listed